Fabiani, I., Tacconi, D., Grotti, S., et al. (2011) Amiodar-one-induced pulmonary toxicity mimicking acute pulmonary edema. Journal of Cardiovascular Medicine, 12, 361-365.
http://dx.doi.org/10.2459/JCM.0b013e328334a3f4

has been cited by the following article:

• TITLE: Amiodarone-induced bronchiolitis obliterans organizing pneumonia in patient following percutaneous transluminal coronary angioplasty

  AUTHORS: Massimo Bolognesi, Diletta Bolognesi

  KEYWORDS: Percutaneous Transluminal Coronary Angioplasty; Amiodarone; BOOP

  JOURNAL NAME: Case Reports in Clinical Medicine, Vol.2 No.9, December 13, 2013

  ABSTRACT: Background: Many patients are affected by idiopathicbronchiolitis obliterans organizing pneumonia (BOOP). There are several known causes of BOOP, and several systemic disorders have BOOP as an associated primary pulmonary lesion. Numerous agents including cytotoxic and noncytotoxic drugs have the potential to cause pulmonary toxicity. Descriptions of amiodarone-related BOOP continue to be reported throughout the world. Case Report: We reported a patient with original clinical presentation who developed recurrent sustained ventricular tachycardia (SVT) despite the presence of implantable cardioverter-defibrillator (ICD), hypoxaemia and interstitial pneumonitis in both lung bases. After percutaneous transluminal coronary angioplasty, he developed bronchiolitis obliterans organizing pneumonia (BOOP). Conclusions: To our knowledge, such complications after percutaneous coronary procedure in patients with amiodarone therapy for arrhythmia prophylaxis, are not very frequent in literature.